Published in Cell Death Differ on July 02, 2010
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis (2011) 1.76
Role of apoptosis in disease. Aging (Albany NY) (2012) 1.58
Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. EMBO Mol Med (2012) 1.14
MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci (2014) 0.97
PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR Res (2012) 0.83
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood (2016) 0.80
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. Pigment Cell Melanoma Res (2012) 0.79
Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib. Cell Discov (2015) 0.78
Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue. Oncotarget (2014) 0.77
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res (2002) 8.55
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell (1993) 5.00
Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet (2004) 3.78
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med (2006) 2.30
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol (2004) 2.08
Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J Immunol (1996) 1.86
Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol (1997) 1.72
In vitro and in vivo anti-melanoma effects of ciglitazone. J Invest Dermatol (2009) 1.67
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
NF-kappaB activation in melanoma. Pigment Cell Res (2006) 1.55
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol (2000) 1.48
A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet (1994) 1.44
Melanoma and the tumor microenvironment. Curr Oncol Rep (2008) 1.26
Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene (2003) 1.23
The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res (2009) 1.18
Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res (2006) 1.17
Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem (2007) 1.12
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11
Activated ras. Yet another player in melanoma? Am J Pathol (1996) 1.05
Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. Blood (2007) 1.03
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. Genes Dev (2005) 1.02
Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J Cell Biochem (1990) 1.00
Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res (2001) 0.97
Epidemiology and prevention of cutaneous melanoma. Curr Treat Options Oncol (2006) 0.94
Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro. Anticancer Drugs (2006) 0.89
PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells. Int J Biochem Cell Biol (2008) 0.88
PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91. Pigment Cell Melanoma Res (2008) 0.88
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res (2003) 0.86
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma. Invest New Drugs (2004) 0.84
Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J Cell Biochem (1987) 0.84
Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. Arch Dermatol Res (2006) 0.81
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet (1998) 8.02
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res (2000) 2.98
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene (2011) 2.49
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity (1996) 1.95
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene (2011) 1.83
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis (2011) 1.76
Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology (2000) 1.75
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene (2010) 1.68
In vitro and in vivo anti-melanoma effects of ciglitazone. J Invest Dermatol (2009) 1.67
p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J Biol Chem (1999) 1.66
A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation. Immunity (2000) 1.65
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy (2006) 1.57
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy. Infection (2014) 1.55
Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature (1985) 1.50
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem (1993) 1.48
Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem (2000) 1.45
Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology (2002) 1.45
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol (2007) 1.44
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40
Changed epidemiology of ICU acquired bloodstream infections over 12 years in an Italian teaching hospital. Minerva Anestesiol (2014) 1.40
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene (2011) 1.38
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia (2011) 1.37
The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med (Berl) (2001) 1.36
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36
Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. J Biol Chem (1990) 1.36
Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol (1999) 1.35
Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J Biol Chem (1996) 1.31
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene (2009) 1.30
Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ (2012) 1.27
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem (1995) 1.27
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem (1996) 1.27
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord (2000) 1.25
Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity (1998) 1.25
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. Cell Growth Differ (1999) 1.21
The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect (2000) 1.18
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia (2007) 1.18
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem (1996) 1.18
A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet (1998) 1.17
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene (2000) 1.15
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
Identification of a cellular 110 000-Da protein substrate for the insulin-receptor kinase. Biochem J (1985) 1.15
Views on Vav. Immunol Today (1997) 1.15
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13
Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ (2008) 1.11
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11
Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3. Studies in human platelets ans transfected Chinese hamster ovary cells. J Biol Chem (2000) 1.10
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10
Congenital erythropoietic porphyria (Günther's disease): enzymatic studies on two cases of late onset. J Lab Clin Med (1981) 1.09
Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J Neuroimmunol (1991) 1.08
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene (2006) 1.08
Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J Virol (1997) 1.07
Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ (1995) 1.07
Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci (2000) 1.07
Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest (1985) 1.06
Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene (2007) 1.06
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol (2008) 1.06
The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J Immunol (1995) 1.05
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care (1996) 1.05
Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J Immunol (1997) 1.05
Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol (2011) 1.04
C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor. J Biol Chem (1999) 1.04
Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation. Eur J Immunol (2000) 1.03
The retinoblastoma-like protein p130 is involved in the determination of reserve cells in differentiating myoblasts. Curr Biol (2000) 1.03
Defective barrier function in melasma skin. J Eur Acad Dermatol Venereol (2011) 1.02
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.02
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. Br J Dermatol (2012) 1.01
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest (1997) 1.01